Cargando…

Multi-nutrient supplement improves hormone ratio associated with cancer risk

BACKGROUND: Gynecological cancers are among the most common in women and are directly related to a variety of hormonal factors. One potential risk factor associated with developing a gynecological malignancy is the ratio of two hormone metabolites, 2-Hydroxyestrone (2-HE) and 16alpha-Hydroxyestrone...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazzan, Anthony J, Zabrecky, George P, Newberg, Andrew B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852270/
https://www.ncbi.nlm.nih.gov/pubmed/24103703
http://dx.doi.org/10.1186/1479-5876-11-252
_version_ 1782478638500806656
author Bazzan, Anthony J
Zabrecky, George P
Newberg, Andrew B
author_facet Bazzan, Anthony J
Zabrecky, George P
Newberg, Andrew B
author_sort Bazzan, Anthony J
collection PubMed
description BACKGROUND: Gynecological cancers are among the most common in women and are directly related to a variety of hormonal factors. One potential risk factor associated with developing a gynecological malignancy is the ratio of two hormone metabolites, 2-Hydroxyestrone (2-HE) and 16alpha-Hydroxyestrone (16alpha-HE). A number of botanical constituents such as indoles, flavonoids, and resveratrol have been shown to have a favorable effect on the metabolic pathways that affect this ratio. The present study was designed to evaluate if a multi-nutrient supplement containing targeted botanical constituents would affect the 2-HE/16 alpha-HE ratio in middle-aged women. METHODS: A retrospective analysis was performed on 76 female patients (mean age 54 years) who received 2-HE/16 alpha-HE ratio assessments at two separate time points. The ratio assessment was part of standard care for women who presented with risk indicators associated with a high proliferative state. All patients who completed pre and post assessments were included. Sixty-five of the patients received a multi-nutrient supplement, Lucentia Peak®, during the study period. Eleven patients chose not to take the supplement, but did receive ratio assessments at similar time points as the treatment group, allowing for between group comparisons. Paired t-tests were used to compare the changes in the 2-HE and 16alpha-HE measures as well as their ratio, both within groups and between groups. RESULTS: The results demonstrated a significant increase in the 2-HE/16alpha-HE ratio in the treated group (pre 0.38 to post 0.57, p<0.0001), and was significantly different (p=0.02) compared to the change in the control group (pre 0.65 to post 0.64). This change appears to be mediated primarily by an increase in the 2-HE level. Individually, 54 patients given Lucentia Peak® had increased ratios while 11 patients had a decrease. In the control group, 3 patients had an increase in their ratio and 8 patients had a decrease. CONCLUSIONS: The results demonstrated that women receiving the Lucentia Peak® multi-nutrient supplement had significant increases in their 2-HE:16alpha-HE ratio, which appears to be mediated primarily by increasing the 2-HE levels. These results suggest further research on phytonutrients that might positively affect estrogen metabolism is warranted.
format Online
Article
Text
id pubmed-3852270
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38522702013-12-06 Multi-nutrient supplement improves hormone ratio associated with cancer risk Bazzan, Anthony J Zabrecky, George P Newberg, Andrew B J Transl Med Research BACKGROUND: Gynecological cancers are among the most common in women and are directly related to a variety of hormonal factors. One potential risk factor associated with developing a gynecological malignancy is the ratio of two hormone metabolites, 2-Hydroxyestrone (2-HE) and 16alpha-Hydroxyestrone (16alpha-HE). A number of botanical constituents such as indoles, flavonoids, and resveratrol have been shown to have a favorable effect on the metabolic pathways that affect this ratio. The present study was designed to evaluate if a multi-nutrient supplement containing targeted botanical constituents would affect the 2-HE/16 alpha-HE ratio in middle-aged women. METHODS: A retrospective analysis was performed on 76 female patients (mean age 54 years) who received 2-HE/16 alpha-HE ratio assessments at two separate time points. The ratio assessment was part of standard care for women who presented with risk indicators associated with a high proliferative state. All patients who completed pre and post assessments were included. Sixty-five of the patients received a multi-nutrient supplement, Lucentia Peak®, during the study period. Eleven patients chose not to take the supplement, but did receive ratio assessments at similar time points as the treatment group, allowing for between group comparisons. Paired t-tests were used to compare the changes in the 2-HE and 16alpha-HE measures as well as their ratio, both within groups and between groups. RESULTS: The results demonstrated a significant increase in the 2-HE/16alpha-HE ratio in the treated group (pre 0.38 to post 0.57, p<0.0001), and was significantly different (p=0.02) compared to the change in the control group (pre 0.65 to post 0.64). This change appears to be mediated primarily by an increase in the 2-HE level. Individually, 54 patients given Lucentia Peak® had increased ratios while 11 patients had a decrease. In the control group, 3 patients had an increase in their ratio and 8 patients had a decrease. CONCLUSIONS: The results demonstrated that women receiving the Lucentia Peak® multi-nutrient supplement had significant increases in their 2-HE:16alpha-HE ratio, which appears to be mediated primarily by increasing the 2-HE levels. These results suggest further research on phytonutrients that might positively affect estrogen metabolism is warranted. BioMed Central 2013-10-08 /pmc/articles/PMC3852270/ /pubmed/24103703 http://dx.doi.org/10.1186/1479-5876-11-252 Text en Copyright © 2013 Bazzan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bazzan, Anthony J
Zabrecky, George P
Newberg, Andrew B
Multi-nutrient supplement improves hormone ratio associated with cancer risk
title Multi-nutrient supplement improves hormone ratio associated with cancer risk
title_full Multi-nutrient supplement improves hormone ratio associated with cancer risk
title_fullStr Multi-nutrient supplement improves hormone ratio associated with cancer risk
title_full_unstemmed Multi-nutrient supplement improves hormone ratio associated with cancer risk
title_short Multi-nutrient supplement improves hormone ratio associated with cancer risk
title_sort multi-nutrient supplement improves hormone ratio associated with cancer risk
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852270/
https://www.ncbi.nlm.nih.gov/pubmed/24103703
http://dx.doi.org/10.1186/1479-5876-11-252
work_keys_str_mv AT bazzananthonyj multinutrientsupplementimproveshormoneratioassociatedwithcancerrisk
AT zabreckygeorgep multinutrientsupplementimproveshormoneratioassociatedwithcancerrisk
AT newbergandrewb multinutrientsupplementimproveshormoneratioassociatedwithcancerrisk